In today's Morning Movers, we... Getty Images •...observe the bulls staying bullish despite the selloff; •...explain why Foundation Medicine (FMI) up nearly 30% despite the generalized pain; •...and highlight a bluebird bio (BLUE) upgrade. bluebird bio (BLUE) is up 1% to $178.50 after Evercore ISI upgraded it to Outperform. Bleakley Advisory Group's Peter Boockvar notes that the end result of an escalating trade war is slower economic growth and higher inflation.